Latest News

Novel proprietary triple low-dose combination pill has been shown to outperform traditional blood pressure treatments without additional side effects in earlier clinical research. Lead candidate in Company’s pipeline of proprietary fixed-dose combination therapies targeting high unmet need in large patient populations suffering from non-communicable diseases such...

When clinical trials become a normal part of care options for patients with unmet needs, both researchers and patients will reap exponential rewards. “Where are the patients?” Clinical trials hinge on recruitment, and enrollment issues are a perpetual challenge. Research estimates that, on average, around 20-25%...

The George Institute for Global Health is delighted to announce the launch of The Scan, a new podcast exploring the latest research, emerging evidence, and progress towards improving health outcomes in non-communicable diseases and injury around the world. Each episode of The Scan will deep dive into a new...

The AustralaSian COVID-19 Trial (ASCOT) has been expanded into India, with the first patients recruited to the first two sites, Christian Medical College and Hospital Ludhiana in Punjab and Sterling Multispecialty Hospital in Pune, Maharashtra. ASCOT aims to discover which existing treatments are most effective in patients...

Affordable dialysis worldwide: Q+A with John Knight of Ellen Medical Devices about the world’s first low-cost dialysis system.   Professor John Knight, a children’s kidney specialist, is the Managing Director of Ellen Medical Devices and a senior researcher at The George Institute for Global Health. He speaks...